|
Report ID
|
175814 |
|
Drug Identification Number
|
02491338 |
|
Brand name
|
METHOTREXATE SUBCUTANEOUS |
|
Common or Proper name
|
METHOTREXATE SODIUM |
|
Company Name
|
ACCORD HEALTHCARE INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
METHOTREXATE |
|
Strength(s)
|
17.5MG |
|
Dosage form(s)
|
SOLUTION |
|
Route of administration
|
SUBCUTANEOUS |
|
Packaging size
|
1 |
|
Anatomical Therapeutical Chemical (ATC) code
|
L04AX |
|
Anatomical Therapeutical Chemical (ATC) description
|
IMMUNOSUPPRESSANTS |
|
Reason for shortage
|
Disruption of the manufacture of the drug. |
|
Anticipated start date
|
|
|
Actual start date
|
2022-11-26 |
|
Estimated end date
|
2023-06-29 |
|
Actual end date
|
2023-06-29 |
|
Shortage status
|
Resolved |
|
Updated date
|
2023-06-30 |
|
Company comments
|
|
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
